OPP001 📄 Overview Develop a SaMD that creates a personalized 'digital twin' for individuals with chronic conditions (e.g., Type 2 Diabetes, CHF). This twin integrates real-time data from wearables (glucose, HR, activity), EHRs, genomics, and patient-reported lifestyle factors. AI models then simulate the impact of various interventions (dietary changes, medication adjustments, exercise routines) to provide predictive insights and personalized recommendations, optimized for individual outcomes and risk profiles. Key technologies: 👤 Target users: 👍 Benefits Highly personalized treatment plans • Early detection of decompensation • Reduced hospitalizations and complications • Improved medication adherence and lifestyle choices • Lower healthcare costs through proactive management Use bullets or new lines. 👎 Challenges Data interoperability across disparate systems • Validation of AI model accuracy and generalizability across diverse populations • Regulatory clearance for adaptive AI algorithms • Ensuring patient comprehension and trust in AI-driven recommendations • Scalability and integration into clinical workflows 📋 Regulatory & Validation Likely Class II or Class III SaMD due to diagnostic and treatment implications. • Requires robust clinical validation studies demonstrating safety and effectiveness. • Clear guidance on algorithm modification protocols for AI/ML-based SaMD (e.g., FDA's 'Predetermined Change Control Plan'). • Strict adherence to data privacy regulations (HIPAA, GDPR) due to sensitive health data.